Live: Novo Faces New Challenges After Blockbuster Success of Ozempic and Wegovy
Novo Nordisk, the Danish pharmaceutical company behind popular weight loss drugs Ozempic and Wegovy, experienced significant growth driven by the global demand for these treatments. The drugs, initially developed for…